Sat.Mar 13, 2021 - Fri.Mar 19, 2021

The Apple Watch in clinical trials: Current uses and future possibilities

Bio Pharma Dive

Why the Apple Watch will likely be one of the top choices for use by sponsors, CROs and clinical trial teams wishing to use wearables in their trials

Pharma’s reputational high will be short-lived

World of DTC Marketing

SUMMARY: Via the Financial Times , “pharmaceutical companies have never had it so good.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New research adds to evidence that POTS may be an autoimmune disorder

Scienmag

Persistent work from scientists at The University of Toledo could aid in diagnosing and treating postural orthostatic tachycardia syndrome Credit: Daniel Miller / The University of Toledo The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding.

IBM-led group wins German contract for digital vaccine passport

Pharma Phorum

Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates. The €2.7 million ($3.2

A first-of-its-kind mRNA drug falls short in cystic fibrosis

Bio Pharma Dive

A treatment that sprays synthetic messenger RNA into the lungs failed to help cystic fibrosis patients, a blow to efforts to use the technology for more than vaccines

RNA 222

Dear FDA: WTF?

World of DTC Marketing

SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs.

How our microplastic waste becomes ‘hubs’ for pathogens, antibiotic-resistant bacteria

Scienmag

More Trending

Record funding flowed into cell, gene therapy companies last year

Bio Pharma Dive

Nearly $20 billion was invested in biotechs developing cell-, gene- and tissue-based treatments in 2020, according to a new report from industry group ARM

Do pharma marketers have a responsibility to the public?

World of DTC Marketing

IN BRIEF: As a marketer, most of us, like a Jungian archetype, are true Communicators. Yet are those skills only reserved for big budgets, bold pitches, and grand innovations? Or do we, as individuals, have a special responsibility to the public at this moment in time?

DeepVerge’s nanochip-based COVID breath test could be ready this year

Pharma Phorum

DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it.

FDA Halts bamlanivimab Distribution in Three States as COVID-19 Variants Spread

BioSpace

The FDA will limit the use of monoclonal antibody treatments developed by Regeneron and Eli Lilly due to concerns the medications are not effective against these new strains

FTC joins overseas antitrust regulators in examination of pharma M&A

Bio Pharma Dive

The commission, along with agencies in Europe, Canada and the U.K., plans to take a broader view of the potential anti-competitive effects to drug company acquisitions

Value-Based healthcare won’t work

World of DTC Marketing

SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes.

AZ’s vaccine safety review shows ‘no evidence’ of an increased risk of blood clots

Pharma Times

Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab

Data Suggests UK COVID-19 Strain Increases Risk of Death By More Than 60%

BioSpace

A study published in the journal Nature suggest the U.K. strain may cause a 61% higher risk of 28-day mortality

103
103

Gilead, Merck combine forces in HIV

Bio Pharma Dive

The rivals are now working together on oral and injectable treatments that combine their closely watched experimental drugs lenacapavir and islatravir

Drugs 202

Bioengineers learn the secrets to precisely turning on and off genes

Scienmag

Credit: Thomas Gorochowski In a recent study led by the University of Bristol, scientists have shown how to simultaneously harness multiple forms of regulation in living cells to strictly control gene expression and open new avenues for improved biotechnologies.

Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why More Physicians Now Use Genetic Tests and How Payers Want to Control Utilization, Prices

BioTech 365

Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why More Physicians Now Use Genetic Tests and How Payers Want to Control Utilization, Prices Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why … Continue reading → Business Wire

AstraZeneca Troubles Continue as Study Shows Ineffectiveness Against South African Variant

BioSpace

France and Germany are two out of more than a dozen countries that suspended deployment of the AstraZeneca-Oxford University vaccine after reports of blood clots were reported

Lilly lays out 2-year plan to gain approval for Alzheimer's drug

Bio Pharma Dive

Study results for donanemab showed signs of slowing disease progression, but the company believes the FDA won't review until another study confirms that apparent benefit

Drugs 193

Artificial neuron device could shrink energy use and size of neural network hardware

Scienmag

Credit: Sangheon Oh/Nature Nanotechnology Training neural networks to perform tasks, such as recognizing images or navigating self-driving cars, could one day require less computing power and hardware thanks to a new artificial neuron device developed by researchers at the University of California San Diego.

Could a smartphone cough app stop future pandemics?

Pharma Phorum

A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. .

How To Get a Financial Fresh Start With Upsolve

Triage Cancer

Extremely high medical bills are a huge problem in the United States, particularly for the cancer community. That’s why we are proud to announce our partnership with Upsolve , a free bankruptcy tool. Most people don’t realize that normally, filing for bankruptcy actually costs money.

65

AstraZeneca says 'no evidence' linking vaccine to clots after multiple countries pause rollout

Bio Pharma Dive

The drugmaker defended its shot following reports of blood clots among vaccine recipients, noting more than 17 million people in the U.K. and Europe have now received it

Novel coronavirus circulated undetected months before first COVID-19 cases in Wuhan, China

Scienmag

FDA to Consider Allowing Trials for Algernon’s Psychedelic DMT

BioSpace

Algernon Pharmaceuticals has requested a pre-Investigational New Drug meeting with regulators in the hopes of launching a clinical trial in stroke patients for n,n-dimethyltryptamine, a naturally derived psychedelic compound

How U.S. Ratings of Nursing Homes Mislead the Public

NY Times

Nursing homes have manipulated the influential star system in ways that have masked deep problems — and left them unprepared for Covid-19.

Detailed Lilly data give mixed picture of Alzheimer's drug's benefit

Bio Pharma Dive

Highly anticipated results from a Phase 2 study of donanemab showed treatment slowed disease progression, but mixed data on other measures could temper optimism in its potential

Drugs 180

For the first time, an Alpine-wide study shows that snow cover has been declinin

Scienmag

Less snow in winter, especially below 2,000 metres and less in spring at all altitudes, in all regions Credit: Eurac Research The results, published in the renowned scientific journal The Cryosphere, have made it possible to reliably describe snow trends at up to 2000 metres above sea level.

Russia Sees Opportunity in Europe as AstraZeneca’s COVID-19 Vaccine Falters

BioSpace

With more European countries pausing dosing of AstraZeneca’s COVID-19 vaccine over concerns about potential blood clotting side effects, Russia is seeking to fill in the gaps with its Sputnik V vaccine

How to Ensure Patient Safety During a Clinical Trial

Cloudbyz

Monitoring patient safety during a clinical trial is one of the founding principles to be followed throughout the drug development life cycle. It can be defined as a collaborative relationship between sponsors, sites, researchers, and everyone involved in the clinical trial phases.

AbbVie's approval delay raises further concerns about JAK drugs

Bio Pharma Dive

An FDA request for more data, which comes on the heels of troubling results from a safety study of Pfizer's Xeljanz, could push back by three months AbbVie's plans to get Rinvoq approved in psoriatic arthritis

Drugs 173

National poll: Pandemic has negatively impacted teens’ mental health

Scienmag

Nearly half of parents have noticed a new or worsening mental health condition in their teen since the pandemic started; 3 in 4 say COVID-19 has negatively affected teens’ social interactions. Credit: C.S.

HIV Leaders Merck and Gilead to Team Up on Potential Game-Changer

BioSpace

Two of the biggest drugmakers in the HIV space are teaming up on a combination therapy that has the potential to be a game-changer for patients diagnosed with the dangerous virus for which there is no known cure

91

The digital transformation of pharma’s physician engagement strategies

Pharma Phorum

The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma.

Three drugmakers nab $639M as biotech's IPO pace eclipses a record year

Bio Pharma Dive

Nineteen biotechs have now gone public in the first quarter of 2021, raising a combined $3.6 billion and continuing a surge that began during the coronavirus pandemic

169
169

Endocrine disruptors threatens semen quality

Scienmag

Scientists from UNIGE and IRSET have established a link between poor semen quality in adult men and their mothers’ occupational exposure to endocrine disruptors during pregnancy.